Metsera

Metsera Debt/EBITDA

Delisted

The Total Debt to EBITDA Ratio of Metsera (MTSR) as of Nov 3, 2026 is -0.04.

Debt/EBITDA

-0.04

Last updated:

Total Debt to EBITDA Ratio of Metsera is 2024 -0.04 . Total Debt to EBITDA Ratio of Metsera was 2023 0.00 . It decreases by % lower compared to the previous year.

The Metsera Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2022
-22.76 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
-0.04 USD
The Metsera Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.04—
0.00-100.00%
-22.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Total Debt to EBITDA Ratio of Metsera is -0.04 in 2024.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Metsera since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Metsera with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Metsera

All Key Metrics — Metsera